3 - 9 December 2016
These are links to news stories from the last week that may be of interest to people in the UK. The link beneath each item will take you to the original story.
Please note that the MS Trust did not write the original items and does not endorse their content nor any claims made in them.
To keep up to date on all the latest news, views and research on multiple sclerosis, sign up for Open Door, our free newsletter or regular email alerts
Copaxone and pregnancy recommendations changed
Following a review of data on women who became pregnant whilst taking the drug, the contraindication on using Copaxone (glatiramer acetate) (20mg) during pregnancy has been removed from the label. However, it is still suggested that treatment with Copaxone is avoided during pregnancy.
MS Trust link: Pregnancy
Disease modifying treatment in more advanced stage MS
An Australian study found that it was possible to alter the course of relapsing remitting MS even when treatment was started at a more advanced stage (up to EDSS 6.0). The report didn't look at specific disease modifying drugs
Source: MS Research Australia
MS Trust link: MS Decisions - a guide to the disease modifying drugs for relapsing MS